Abiopharma

🔍 Triplett Neal F (Director)

Company: ARCH CAPITAL GROUP LTD. (ACGL)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 2,071 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,686.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,327 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,013.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Subject to the terms of the restricted share agreement, represents restricted shares that will become vested on the date that is the earlier of 1) one year following the grant date or 2) Arch Capital Group Ltd.'s next Annual General Meeting of Shareholders.
• F2: Represents shares granted as part of the director-elected annual retainer for serving as a director of the Issuer.